2 deals
Biomedical Translation Bridge Program grants $1m to develop a drug treatment for obesity-related health conditions
Cincera Therapeutics has received a million-dollar Biomedical Translation Bridge grant to advance its Des-1 inhibitor drug for obesity-related metabolic diseases. The Monash and UniSA spin-out previously secured venture funding from the Medical Research Commercialisation Fund.